(Q34627358)

3 August 2017

title

Intake of dietary magnesium and the prevalence of the metabolic syndrome among U.S. adults (English)

1 reference

3 August 2017

0 references

1 reference

1

Earl S Ford

1 reference

3 August 2017

5

Simin Liu

1 reference

3 August 2017

4

Ali H Mokdad

1 reference

3 August 2017

Chaoyang Li

2

1 reference

3 August 2017

Lisa C McGuire

series ordinal

3

1 reference

3 August 2017

publication date

1 May 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

15

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

1139-1146

1 reference

Magnesium deficiency produces insulin resistance and increased thromboxane synthesis

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Magnesium, insulin resistance and body composition in healthy postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Prevalence of the metabolic syndrome in US populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

The metabolic syndrome: prevalence in worldwide populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

A major health hazard: the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Sedentary behavior, physical activity, and the metabolic syndrome among U.S. adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Magnesium may mediate the favorable impact of whole grains on insulin sensitivity by acting as a mild calcium antagonist

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Magnesium intake and incidence of metabolic syndrome among young adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Low serum magnesium levels and metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Increasing prevalence of the metabolic syndrome among u.s. Adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Dietary magnesium intake in a national sample of US adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Dietary magnesium intake and blood pressure: a qualitative overview of the observational studies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Does dietary magnesium modulate blood lipids?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

The effects of high oral magnesium supplementation on blood pressure, serum lipids and related variables in apparently healthy Japanese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Atherogenic lipid fractions are related to ionized magnesium status

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Daily magnesium supplements improve glucose handling in elderly subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Correlates of fasting insulin levels in young adults: the CARDIA study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Low dietary magnesium is associated with insulin resistance in a sample of young, nondiabetic Black Americans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

Magnesium deficiency is associated with insulin resistance in obese children.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2007.628

31 March 2020

Identifiers

DOI

10.1038/OBY.2007.628

1 reference

3 August 2017

1 reference